Please note that this guideline will update and replace recommendations relating to risk assessment and lipids management for type 1 and type 2 diabetes and chronic kidney disease, and statin therapy for people at increased risk of developing cardiovascular disease or those with established cardiovascular disease:

• CG15 Type 1 diabetes Sections 1.10.1 and 1.10.2   
• CG87 Type 2 diabetes Sections 1.9 and 1.10
• CG73 Chronic kidney disease Recommendations 1.8.19 and 1.8.20
• TA94 Statins for the prevention of cardiovascular events